Dr. Torres is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Nephrology, 1977 - 1979- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1975 - 1977
Aurora Health CareResidency, Internal Medicine, 1974 - 1975- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1972 - 1974
Universidad de Barcelona Faculty of MedicineClass of 1969
Certifications & Licensure
MN State Medical License 1976 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
Clinical Trials
- HALT Progression of Polycystic Kidney Disease Study A Start of enrollment: 2006 Jan 01
- Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 1024 citationsTolvaptan in patients with autosomal dominant polycystic kidney diseaseVicente E. Torres, Arlene B. Chapman, Olivier Devuyst, Ron T. Gansevoort, Jared J. Grantham
The New England Journal of Medicine. 2012-12-20 - 135 citationsClinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials DatabasePaul B. Watkins, James H. Lewis, Neil Kaplowitz, David H. Alpers, Jaime D. Blais
Drug Safety. 2015-11-01 - 490 citationsInhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist.Vincent H. Gattone, Xiaofang Wang, Peter C. Harris, Vicente E. Torres
Nature Medicine. 2003-09-21
Journal Articles
- A Practical Guide for Treatment of Rapidly Progressive ADPKD with TolvaptanRonald D Perrone, Anjay Rastogi, Terry Watnick, Arlene B Chapman, Michal Mrug, Vicente E Torres, Fouad T Chebib, Neera K Dahl, Peter C Harris, Journal of the American Society of Nephrology
- Recent Advances in the Management of Autosomal Dominant Polycystic Kidney DiseaseFouad T Chebib, Vicente E Torres, Journal of the American Society of Nephrology
Lectures
- Autosomal Dominant Polycystic Kidney Disease: Approach to Patient Assessment and ManagementAmerican Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/8/2019
Other
- Three‐Dimensional NMR Microscopy of Zebrafish SpecimensVicente Torres, MD, NMR in Biomedicine
https://www.doximity.com/articles/01448d77-3f9b-4d03-8a38-97353008c5df
UpToDate, Wolters Kluwer Health - 2013-01-11 - Three‐Dimensional NMR Microscopy of Zebrafish SpecimensVicente Torres, MD, NMR in Biomedicine
https://www.doximity.com/articles/01448d77-3f9b-4d03-8a38-97353008c5df
UpToDate, Wolters Kluwer Health - 2012-12-19
Press Mentions
- KDIGO to Develop New Guideline for Autosomal Dominant Polycystic Kidney DiseaseNovember 5th, 2020
Father’s Battle with Kidney Disease Fuels Researcher’s Determination to Find CureDecember 12th, 2018
Promising Treatment for Inherited Form of Kidney DiseaseNovember 4th, 2012- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
